Bravecto should be administered topically as a single dose every 12 weeks according to the Dosage
Schedule below to provide a minimum dose of 11.4 mg/lb (25 mg/kg) body weight.
Bravecto may be administered every 8 weeks in case of potential exposure to Amblyomma americanum
ticks (see Effectiveness).
Contraindications: There are no known contraindications for the use of the product.
|Body Weight Ranges (lb)
||Fluralaner Content (mg)/tube
*dogs over 123.0 lbs should be administered the appropriate combination of tubes.
Do not store above 77°F (25°C). Store in the original package in order to protect from moisture. The pouch should only be opened immediately prior to use.
Who is Bravecto Topical Solution for Dogs for?
For Dogs and Puppies 6 months of age and older weighing 4.4 pounds or greater
How does Bravecto Topical Solution for Dogs work?
Fluralaner is for systemic use and belongs to the class of isoxazoline-substituted benzamide derivatives. Fluralaner is an inhibitor of the arthropod nervous system. The mode of action of fluralaner is the antagonism of the ligand-gated chloride channels (gamma-aminobutyric acid (GABA)-receptor and glutamate-receptor).
Why use Bravecto Topical Solution for Dogs?
Provides flea and tick treatment for up to 12 weeks (8 weeks for the lone star tick) in just 1 dose
Treatment may begin at any time of the year and can continue year round without interruption
Bathing or water immersion 3 days after administration will not reduce the effectiveness of Bravecto against fleas and Ixodes ricinus ticks
Longest-lasting protection available in a topical solution
Available by veterinary prescription only
In well-controlled laboratory studies, Bravecto killed fleas and reduced the numbers of live fleas on dogs by >99% and 100% within 24 and 48 hours, respectively, post-infestation for 12 weeks. In well-controlled laboratory studies, Bravecto demonstrated ?93.3% effectiveness against Dermacentor variabilis, Ixodes scapularis and Rhipicephalus sanguineus 48 hours post-infestation for 12 weeks. Bravecto demonstrated ?90% effectiveness against Amblyomma americanum 72 hours post-infestation for 8 weeks, but failed to demonstrate ?90% effectiveness beyond 8 weeks.
In a well-controlled U.S. field study, a single dose of Bravecto reduced fleas by ?99.8% for 12 weeks. Dogs with signs of flea allergy dermatitis showed improvement in erythema, alopecia, papules, scales, crusts, and excoriation as a direct result of eliminating flea infestations.
In a European laboratory study, Bravecto demonstrated ?98.2% effectiveness against fleas and Ixodes
ricinus ticks after multiple water immersion or shampooing occasions, the first occurring 3 days after
application, for 12 weeks.